Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study

Abstract Introduction Data suggest that women and men differ in how they experience biological treatment. This post hoc analysis of the YU-MATTER study evaluated sex-related differences in patient satisfaction and perception when switching from adalimumab (reference or biosimilar) to CT-P17 (Yuflyma...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Laure Gossec, Guillaume Bouguen, Azeddine Dellal, Lucile Foulley, Caroline Habauzit, Salim Benkhalifa, Hubert Marotte
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Adis, Springer Healthcare 2026-03-01
Serie:	Rheumatology and Therapy
Soggetti:	Adalimumab Adverse events Biosimilar CT-P17 Injection site reactions Patient-reported outcomes
Accesso online:	https://doi.org/10.1007/s40744-026-00840-7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!